XML 18 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Premiums $ 30,667 $ 25,108 $ 61,058 $ 49,460
Net investment income 394 274 848 608
Total revenues 91,234 88,921 179,671 174,199
Operating costs:        
Cost of products sold 49,998 53,536 98,071 104,991
Health care costs 27,853 21,782 55,656 42,230
Operating expenses 10,338 9,873 20,628 19,453
Restructuring charge 0 496 0 496
Loss on assets held for sale 0 0 0 349
Total operating costs 88,189 85,687 174,355 167,519
Operating income 3,045 3,234 5,316 6,680
Interest expense 732 686 1,448 1,275
Other income (24) (22) (49) (44)
Income before income tax provision 2,337 2,570 3,917 5,449
Income tax provision 569 656 1,025 1,393
Net income 1,768 1,914 2,892 4,056
Net (income) loss attributable to noncontrolling interests 2 (13) (9) (19)
Net income attributable to CVS Health $ 1,770 $ 1,901 $ 2,883 $ 4,037
Net income per share attributable to CVS Health:        
Basic (in dollars per share) $ 1.41 $ 1.48 $ 2.29 $ 3.15
Diluted (in dollars per share) $ 1.41 $ 1.48 $ 2.28 $ 3.13
Weighted average shares outstanding:        
Basic (in shares) 1,256 1,283 1,258 1,283
Diluted (in shares) 1,259 1,287 1,263 1,289
Dividends declared per share (in dollars per share) $ 0.665 $ 0.605 $ 1.33 $ 1.21
Cost, Product and Service [Extensible List] Products Products Products Products
Products        
Revenues:        
Revenues $ 56,212 $ 60,539 $ 109,936 $ 118,686
Services        
Revenues:        
Revenues $ 3,961 $ 3,000 $ 7,829 $ 5,445